Cornell Cancer & Oncology Research

80 recent oncology and cancer research papers authored by Cornell University faculty and affiliates, drawn from arXiv, newest first.

80 listed

• Intravital single-cell behavior profiling reveals disrupted germinal center B cell motility and interactions by EZH2 gain-of-function mutation2026-09-06
  Xi Chen, Chris Xu
  arXiv ↗
• The Global Immune–Nutrition–Inflammation Index (GINI) as a Candidate Prognostic Marker in Patients with Cutaneous Squamous Cell Carcinoma Treated with Cemiplimab2026-09-04
  Aviram Mizrachi
  arXiv ↗
• Truncated ErbB2 receptor expression lowers nucleus stiffness and increases migration of breast cancer cells2026-09-02
  Margaret A. Elpers
  arXiv ↗
• When Historical Housing Policy Shapes Modern Breast Cancer Prevention2026-09-02
  Laura C. Pinheiro
  arXiv ↗
• New Paradigms in the Management of Castleman Disease2026-09-01
  Ariela Noy
  arXiv ↗
• SCLC TumorMiner: A genomics platform for small cell lung cancer precision oncology2026-09-01
  Anisha Tehim
  arXiv ↗
• A Phase I Study of Nab-Paclitaxel, Gemcitabine and AZD1775 for Treatment of Metastatic Adenocarcinoma of the Pancreas: ECOG-ACRIN EA21312026-09-01
  Neal J. Meropol
  arXiv ↗
• Multimodal Machine Learning for Predicting Outcomes in the PASS-01 Trial of Systemic Therapy for Metastatic Pancreatic Cancer2026-08-27
  K. Yu, Eileen M. O'Reilly
  arXiv ↗
• Generation of an induced pluripotent stem cell line from a patient with immune checkpoint inhibitor-induced myocarditis and concurrent type I diabetes2026-08-27
  Yuhsin Vivian Huang
  arXiv ↗
• Biopsied Cutaneous Adverse Effects of PD-1 and PD-L1 Checkpoint Inhibitors and Progression-free Survival: A Retrospective Case Series of 75 Patients2026-08-27
  Julian Willett
  arXiv ↗
• Neoadjuvant Botensilimab/Balstilimab for localized mismatch repair proficient and deficient colon cancer: Results of the NEST phase 2 clinical trial2026-08-26
  Manish A. Shah, Erika Hissong, Mehraneh D. Jafari, Maider Astorkia, Sahrish Khan, Casey Owens, Zhengming Chen, Heather Yeo, Fabio Socciarelli, Sandipto Sarkar,
  arXiv ↗
• Endothelial glycocalyx glycan expression in lymphatic vasculature in mice2026-08-26
  Issahy Cano, Esak Lee
  arXiv ↗
• Outpatient Treatment-Related Toxicity After Hospital Discharge Among Patients Receiving Lifileucel for Advanced Melanoma2026-08-25
  Mia Andreoli, Michael A. Postow, Jae H. Park, Charlotte E. Ariyan, Alexander N. Shoushtari, James W. Smithy
  arXiv ↗
• CellCage™ Technology Enables High-throughput Isolation of Defined Cell Combinations to Resolve the Determinants of CAR-T mediated Cytotoxicity2026-08-25
  Christopher E. Mason
  arXiv ↗
• Tumour-infiltrating lymphocytes and breast radiotherapy: perspectives from the International Immuno-Oncology Biomarker Working Group2026-08-24
  Sandra Demaria, Silvia C. Formenti
  arXiv ↗
• Optimizing methods to detect colonization with fluoroquinolone-resistant viridans group streptococci prior to hematopoietic cell transplantation2026-08-21
  Supram Hosuru Subramanya, Lee Gottesdiener, Jamie Marino, Juliet Barker, Tsiporah Shore, Rosemary Soave, Markus Plate, John R. Lee, Laura B. Goodman, Casey L. C
  arXiv ↗
• MetaFemina: development and evaluation of a large language model-assisted platform for automated meta-analysis of nutritional exposures and breast, ovarian, and uterine cancer risk2026-08-21
  Rulla Tamimi, Saurabh Mehta, Eunji Choi, Zhang Yongxian, Yushu Shi
  arXiv ↗
• Motixafortide, cemiplimab, gemcitabine and nab-paclitaxel in metastatic pancreatic cancer: a single-arm phase 2 study with single-cell correlatives2026-08-21
  Michael May
  arXiv ↗
• Attention U-Net-Based Segmentation and Hybrid Classification for Detection of Circulating Tumor-Associated Cells2026-08-20
  Massimo Cristofanilli
  arXiv ↗
• Longitudinal Phenotyping of Circulating Tumor Cells using a Scalable Deep Learning Framework2026-08-18
  Scott T. Tagawa
  arXiv ↗
• Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Living Guideline, Version 2026.1.22026-08-17
  Manish A. Shah
  arXiv ↗
• A NON-CANONICAL ROLE FOR NOTCH3 IN BUILDING THE INTESTINAL LYMPHATIC NICHE2026-08-15
  Natasza A. Kurpios, Liqing Huang, Bhargav D. Sanketi, Madhav Mantri, YanXi Chen, Clare Wang, Tristan Tran, Iwijn De Vlaminck
  arXiv ↗
• Advancing equitable breast cancer screening: the role of patient-centered education, community outreach, and accessible care pathways2026-08-14
  Shalinie Mahadeo, Katerina Dodelzon, Marina Corines
  arXiv ↗
• BRIGHTLINE-1: When a Negative Trial Reveals Two Active Therapies2026-08-14
  Mrinal M. Gounder
  arXiv ↗
• Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications2026-08-13
  Caitlin Unkenholz, Alison Moskowitz, Santosha Vardhana
  arXiv ↗
• Bispecific CAR T for extramedullary myeloma: a minute waltz2026-08-13
  Hamza Hashmi, Sham Mailankody
  arXiv ↗
• Infectious complications following bispecific antibody or CAR T therapy in adult patients with hematologic malignancies: a retrospective database analysis2026-08-13
  Eleftherios Mylonakis
  arXiv ↗
• Next-Generation Immune Checkpoint Inhibitors in Gastrointestinal Cancers: Mechanisms, Resistance, and Emerging Therapeutic Strategies2026-08-12
  Abdullah Esmail
  arXiv ↗
• Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer2026-08-11
  Wungki Park
  arXiv ↗
• CAR T cell therapy beyond cancer: current status, challenges and future prospects2026-08-11
  Saurabh Upadhyay, Sungwoo Cho, Kirti Upmanyu, Moustafa T. Gabr
  arXiv ↗
• Immune Circuit Rewiring by HDAC Inhibition Enables Response to Dual Checkpoint Blockade in Metastatic Breast Cancer2026-08-11
  Vered Stearns
  arXiv ↗
• Multi-analyte liquid biopsy characterization of metastatic inflammatory breast cancer: comparison with non-inflammatory breast cancer2026-08-06
  Eleonora Nicolò, Letizia Pontolillo, Mara S. Serafini, Nadia Bayou, Brenno Pastò, Hunter Gaudio, Maroua Manai, Carolina Reduzzi, Massimo Cristofanilli
  arXiv ↗
• Weight Loss Responses to Pharmacotherapy in Breast Cancer Survivors: Results from the Adaptive Nutrition and Exercise Weight loss (A-NEW) Study2026-08-04
  Vered Stearns
  arXiv ↗
• POSTER: CT-1505: Infectious Complications and Antibiotic Utilization During the Expected Cytokine Release Syndrome Window After CAR-T Therapy2026-08-01
  Serena Tharakan
  arXiv ↗
• POSTER: IBCL-492: Diagnostic Delays and Comparable Response Rates to iMCD-Directed Therapies in Patients With and Without Expert-Confirmed Idiopathic Multicentric Castleman Disease Diagnoses2026-08-01
  Amy Chadburn
  arXiv ↗
• IBCL-492: Diagnostic Delays and Comparable Response Rates to iMCD-Directed Therapies in Patients With and Without Expert-Confirmed Idiopathic Multicentric Castleman Disease Diagnoses2026-08-01
  Amy Chadburn
  arXiv ↗
• A New Face in the Examination Room: Ethical Implications of Artificial Intelligence Chaperones in Dermatology2026-08-01
  Shari R. Lipner
  arXiv ↗
• Mutant p53 gains RNA-binding activity to reprogram translation and mitochondrial function2026-08-01
  Wuyue Zhou, Cameron J. Douglas, Ciaran P. Seath
  arXiv ↗
• Five-Year Outcomes of Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer From the Randomized KEYNOTE-671 Study2026-08-01
  D.R. Jones, J.E. Chaft
  arXiv ↗
• "I Want What the White Lady Gets...": Deconstructing Racial Disparities in Gynecological Cancer2026-08-01
  Tiffany N. Younger, Onyiye Balogun
  arXiv ↗
• Modeling the synovium on a chip for studying the interactions between lymphatic vasculature and synoviocytes in rheumatoid arthritis2026-07-31
  Samantha Kraus, Issahy Cano, Soo‐Jin Kim, Esak Lee
  arXiv ↗
• Robust CD4 ⁺ CAR T cell expansion is associated with non-ICANS neurotoxicities after ciltacabtagene autoleucel in patients with multiple myeloma2026-07-29
  Sridevi Rajeeve, Alexander M. Lesokhin, Neha Korde, Carlyn Tan, Hamza Hashmi, Hani Hassoun, Kylee Maclachlan, Urvi A. Shah, Malin Hultcrantz, Maximilian Merz, F
  arXiv ↗
• Immune Checkpoint Activation Targeting PD-1H (VISTA) Reinforces Human T-Cell Tolerance in Autoimmunity 23350532026-07-28
  Ziwei Yang
  arXiv ↗
• Novel autochthonous cancer model to investigate TCR signal strength in tumor-specific T cell differentiation 23349052026-07-28
  Sandra Carson
  arXiv ↗
• Co-targeting Deregulated WNT and MAPK Signaling Pathways Limits Phenotypic Reprogramming of Intestinal Stem Cell Progeny in KRAS-Hyperactivated Colorectal Cancer2026-07-28
  Rona Yaeger
  arXiv ↗
• BCMA-directed CAR-T cell therapy induces durable drug-free remission in refractory primary immune thrombocytopenia2026-07-24
  James B. Bussel
  arXiv ↗
• Datopotamab deruxtecan versus chemotherapy in previously treated inoperable/metastatic hormone receptor-positive HER2-negative breast cancer: safety and patient-reported outcomes from the phase III TROPION-Breast01 study2026-07-24
  K. Jhaveri
  arXiv ↗
• ICAM1-targeted costimulation extends HER2 CAR T cytotoxicity to HER2-low and HER2-negative tumors through synergy with TCR signaling2026-07-24
  Yanping Yang, Irene M. Min, Moonsoo M. Jin
  arXiv ↗
• Racial and ethnic disparities in brain-to-vein time among patients receiving CD19 CAR-T cell therapy for relapsed/refractory DLBCL2026-07-22
  Neil Easton, Anna Alperovich, Alexandra Gomez-Arteaga, Sebastian Mayer, Nora Chokr, Tsiporah B. Shore, Juliet Barker, Samuel Yamshon
  arXiv ↗
• Enteric Microbiome Features that Contribute to Gram-Negative Bloodstream Infections in Hematopoietic Cell Transplant Recipients Colonized with Fluoroquinolone-Resistant Enterobacterales2026-07-22
  Grace A. Maldarelli, Jamie Marino, John R. Lee, Lars F Westblade, Michael Hovan, Claire Douglass, Randy S Longman, Michael J. Satlin
  arXiv ↗
• 0062 Establishment of dermatopathology image data base DermpathNet using artificialIntelligence empowered workflow2026-07-21
  Y. Peng
  arXiv ↗
• Neoadjuvant Immune Therapy in Patients With Melanoma: Response and Toxicity in a Non‐Clinical Trial Setting2026-07-19
  Michael A. Postow
  arXiv ↗
• Extracellular vesicles isolated from frozen whole blood show biomarker potential in small intestine neuroendocrine neoplasms2026-07-14
  Linda Bojmar
  arXiv ↗
• MEK-dependent bioenergetic demand drives terminal CD8⁺ T cell exhaustion.2026-07-13
  Tanmana Mitra, Morgan Huse, Santosha A Vardhana
  arXiv ↗
• Comparing the Effectiveness and Safety of Different Third-Line Management Options for Patients with Metastatic Colorectal Cancer: A Systematic Review and Reconstructed Individual Patient Data Meta-Analysis2026-07-08
  Maen Abdelrahim, Abdullah Esmail
  arXiv ↗
• Immune Checkpoint Inhibitors are Associated With Increased Risk of Lichen Planus in a <scp>TriNetX</scp> Analysis2026-07-07
  Shari R. Lipner
  arXiv ↗
• Locus-specific HERV expression identifies an aggressive, NK-depleted, checkpoint-refractory acral melanoma phenotype2026-07-06
  Jez Marston, Tongyi Fei, Matthew L. Bendall, Douglas F. Nixon
  arXiv ↗
• OptiLITT: A Computer-Assisted Planning System for Dual-Fiber Laser Interstitial Thermal Therapy using Cylindrical Ablation Optimization2026-07-06
  Natalie Yeung
  arXiv ↗
• Colorectal cancers with distinct metastatic potential trigger divergent early T cell responses2026-07-04
  Sebastian E. Carrasco, Norihiro Goto
  arXiv ↗
• Anti–PD-(L)1 plus chemotherapy in advanced PD-L1–negative nonsquamous non-small cell lung cancer: a systematic review and meta-analysis2026-07-03
  Alexander Drilon
  arXiv ↗
• Abstract LT02: Aggressive B-cell lymphomas retain ATR-dependent determinants of T-cell exclusion from the Germinal Center Dark Zone2026-07-02
  Giovanni Medico, Maria V. Revuelta, Giorgio Inghirami, Leandro Cerchietti, Roberta Zappasodi
  arXiv ↗
• Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years2026-07-02
  Michael A. Postow
  arXiv ↗
• The clinical picture of ICANS after CAR-T cell therapy in critically ill patients: A retrospective clustering analysis of a multicentre multinational cohort study2026-07-01
  Sanjay Chawla
  arXiv ↗
• Environmentally induced cell stiffening shapes metastatic site selection by tuning the immune vulnerability of cancer cells2026-07-01
  Aliya Holland
  arXiv ↗
• Telling the Whole Story: The Ethics of Cherry-Picking Data in Dermatology2026-07-01
  Shari R. Lipner
  arXiv ↗
• 515P Immune-mediated adverse events (imAEs) in MATTERHORN: A phase III study of durvalumab (D) plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric/gastroesophageal junction (G/GEJ) adenocarcinoma2026-07-01
  D Molena, Y.Y. Janjigian
  arXiv ↗
• 652eTiP Ifinatamab deruxtecan as second or third-line therapy for advanced esophageal squamous cell carcinoma: Substudy 06F of the phase I/II KEYMAKER-U06 study2026-07-01
  M.A. Shah
  arXiv ↗
• Molecular dynamics driving phenotypic divergence among KRAS mutants in pancreatic tumorigenesis2026-07-01
  Adrien Grimont, David J. Falvo, Whitney J. Sisso, Francisco dos Santos, Christopher W. Chan, Paul Zumbo, William B. Fall, Katherine Ferrick, Grace Pan, Megan Cl
  arXiv ↗
• Pancreatic Cancer: Translating Tumor Biology into Actionability2026-07-01
  Fiyinfolu Balogun, Wungki Park, Eileen M. O’Reilly
  arXiv ↗
• Updated patient-reported outcomes and the effect of disease progression on health-related quality of life in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer2026-07-01
  Roisin E. O’Cearbhaill
  arXiv ↗
• Healthcare resource utilization and economic burden of metastatic pancreatic cancer: a US commercial and Medicare claims analysis2026-07-01
  Kenneth H. Yu
  arXiv ↗
• 74531 Optimizing Access to Dermatologic Care: Impact of an Algorithmic Scheduling Strategy on New Patient Visit Lead Times2026-07-01
  Noelle Desir
  arXiv ↗
• 74692 Mapping the Evidence Landscape of Nail Unit Melanoma: A Scoping Review2026-07-01
  Shari Lipner
  arXiv ↗
• Who Writes the Note: The Training Data Behind Artificial Intelligence Scribes in Dermatology2026-07-01
  Shari R. Lipner
  arXiv ↗
• HIV Infection and Opioid Treatment Enable the Engraftment of Kaposi Sarcoma‐Like Tumors Into Immunocompetent Mice2026-06-29
  Anuj Ahuja, Ethel Cesarman
  arXiv ↗
• Multi-dimensional orchestration of binders for improved CAR-T immunotherapy2026-06-28
  Chaoyang Zhu, Z H Jiang, Rui Jing, Wei Guo, Yong Lu
  arXiv ↗
• Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities2026-06-26
  Hui–Hsuan Kuo, Bhavneet Bhinder, Hamza N. Gokozan, Kathryn Gorski, Pooja Chandra, Jyothi Manohar, Daniela Guevara, John Otilano, Jenna Moyer, Marvel Tranquille,
  arXiv ↗
• Langerhans cell control of early-life dermal lymphatic development shapes adult immunity2026-06-26
  Ji Hyun Sim, William Shipman, Niroshana Anandasabapathy, Lionel B. Ivashkiv, Theresa T. Lu
  arXiv ↗
• A Patient-Derived Xenograft Repository Capturing Clinical and Molecular Heterogeneity of Large B-cell Lymphoma2026-06-24
  Giorgio Inghirami
  arXiv ↗
• Abstract A017: A patient derived xenograft repository capturing clinical and molecular heterogeneity of large B-cell lymphoma2026-06-24
  Giorgio Inghirami
  arXiv ↗